These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 22155252)
1. A natural small molecule voacangine inhibits angiogenesis both in vitro and in vivo. Kim Y; Jung HJ; Kwon HJ Biochem Biophys Res Commun; 2012 Jan; 417(1):330-4. PubMed ID: 22155252 [TBL] [Abstract][Full Text] [Related]
2. Matairesinol inhibits angiogenesis via suppression of mitochondrial reactive oxygen species. Lee B; Kim KH; Jung HJ; Kwon HJ Biochem Biophys Res Commun; 2012 Apr; 421(1):76-80. PubMed ID: 22483751 [TBL] [Abstract][Full Text] [Related]
3. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects. Gao W; Jin K; Lan H; Han N; Cao F; Teng L Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543 [TBL] [Abstract][Full Text] [Related]
4. The sphingosine-1-phosphate derivative NHOBTD inhibits angiogenesis both in vitro and in vivo. Kim BS; Park H; Ko SH; Lee WK; Kwon HJ Biochem Biophys Res Commun; 2011 Sep; 413(2):189-93. PubMed ID: 21888894 [TBL] [Abstract][Full Text] [Related]
5. A new anti-angiogenic small molecule, G0811, inhibits angiogenesis via targeting hypoxia inducible factor (HIF)-1α signal transduction. Kim KH; Jung HJ; Kwon HJ Biochem Biophys Res Commun; 2013 Nov; 441(2):399-404. PubMed ID: 24161739 [TBL] [Abstract][Full Text] [Related]
6. γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell. Li Y; Sun WG; Liu HK; Qi GY; Wang Q; Sun XR; Chen BQ; Liu JR J Nutr Biochem; 2011 Dec; 22(12):1127-36. PubMed ID: 21292465 [TBL] [Abstract][Full Text] [Related]
7. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention. Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440 [TBL] [Abstract][Full Text] [Related]
8. R-(-)-beta-O-methylsynephrine, a natural product, inhibits VEGF-induced angiogenesis in vitro and in vivo. Kim NH; Pham NB; Quinn RJ; Kwon HJ Biochem Biophys Res Commun; 2010 Aug; 399(1):20-3. PubMed ID: 20643105 [TBL] [Abstract][Full Text] [Related]
9. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro. Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951 [TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha. Forooghian F; Das B Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204 [TBL] [Abstract][Full Text] [Related]
11. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro. Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705 [TBL] [Abstract][Full Text] [Related]
12. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound. Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195 [TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis. Hussain S; Slevin M; Matou S; Ahmed N; Choudhary MI; Ranjit R; West D; Gaffney J Angiogenesis; 2008; 11(3):245-56. PubMed ID: 18330714 [TBL] [Abstract][Full Text] [Related]
14. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis. DeNiro M; Alsmadi O; Al-Mohanna F Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810 [TBL] [Abstract][Full Text] [Related]
15. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF. Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517 [TBL] [Abstract][Full Text] [Related]
16. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor. Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116 [TBL] [Abstract][Full Text] [Related]
17. Ferulic acid augments angiogenesis via VEGF, PDGF and HIF-1 alpha. Lin CM; Chiu JH; Wu IH; Wang BW; Pan CM; Chen YH J Nutr Biochem; 2010 Jul; 21(7):627-33. PubMed ID: 19443196 [TBL] [Abstract][Full Text] [Related]
18. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP. Pratheeshkumar P; Kuttan G Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125 [TBL] [Abstract][Full Text] [Related]
19. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo. Ueda Y; Yamagishi T; Ikeya H; Hirayama N; Itokawa T; Aozuka Y; Samata K; Nakaike S; Tanaka M; Ono M; Saiki I Anticancer Res; 2004; 24(5A):3009-17. PubMed ID: 15517909 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis. Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]